AtaiBeckley Inc.
Organization
AtaiBeckley Inc. is a clinical-stage biotechnology company focused on developing rapid-acting and convenient treatments for mental health disorders. Formed in late 2025 through the merger of atai Life Sciences and Beckley Psytech, the company researches and develops innovative therapies, including those based on psychedelics and entactogens.
3 episodes featuring AtaiBeckley Inc.
Stock Movers
Netflix slips on weak guidance while Abbott and Eli Lilly surge
Understanding these market movements reveals where corporate giants are placing their long-term bets, from streaming growth limits to emerging biotech frontiers.
Jul 16, 2026 · 7 min
Stock Movers
Eli Lilly targets psychedelics while GE and United Airlines signal growth
This episode highlights how major pharmaceutical acquisitions and corporate restructuring are driving market momentum across healthcare, aerospace, and aviation.
Jul 16, 2026 · 6 min
Stock Movers
Earnings beats and healthcare acquisitions drive major market moves
Understanding these pivotal earnings reports and acquisitions reveals where major capital is flowing in healthcare, tech, and aerospace.
Jul 16, 2026 · 6 min